A. Mathieu-Boué
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Viral-associated cancers and disorders
- Neutropenia and Cancer Infections
- Polyomavirus and related diseases
- Colorectal Cancer Treatments and Studies
- Toxicology top 5%
Papers in
-
- Gastrointestinal Tumor Research and Treatment 4
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Alain GouyetteG. CatimelJanet A. HoughtonR. BugatPeter J. HoughtonPamela J. CheshireG G ChabotMiranda Buitenhuis
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Clinical Cancer Research (1 paper)Anti-Cancer Drugs (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- FranceNetherlandsBelgium
In The Last Decade
A. Mathieu-Boué
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 60
- Oncology 869
- Toxicology 42
- Pathology and Forensic Medicine 204
- Molecular Biology 522
- Transplantation 17
Countries citing papers authored by A. Mathieu-Boué
This map shows the geographic impact of A. Mathieu-Boué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mathieu-Boué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mathieu-Boué more than expected).
Fields of papers citing papers by A. Mathieu-Boué
This network shows the impact of papers produced by A. Mathieu-Boué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mathieu-Boué. The network helps show where A. Mathieu-Boué may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Mathieu-Boué, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 2 | |
| 2 | 2010 | 98 | |
| 3 | 2007 | 9 | |
| 4 | 2007 | 8 | |
| 5 | 2006 | 1 | |
| 6 | 2000 | 285 | |
| 7 | 1998 | 4 | |
| 8 | 1996 | 98 | |
| 9 | 1995 | 94 | |
| 10 | 1995 | 149 | |
| 11 | 1995 | 5 | |
| 12 | Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. | 1994 | 134 |
| 13 | Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin. | 1993 | 148 |
| 14 | 1992 | 71 |
About A. Mathieu-Boué
A. Mathieu-Boué is a scholar working on Gastroenterology, Toxicology, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Neutropenia and Cancer Infections (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Lung Cancer Research Studies (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Viral-associated cancers and disorders (2 papers) and Synthesis and bioactivity of alkaloids (1 paper). The work is most often cited by research in Oncology (869 citations), Toxicology (42 citations), Pathology and Forensic Medicine (204 citations), Molecular Biology (522 citations) and Transplantation (17 citations). A. Mathieu-Boué has collaborated with scholars based in France, Netherlands and Belgium. Frequent co-authors include Alain Gouyette, G. Catimel, Janet A. Houghton, R. Bugat, Peter J. Houghton, Pamela J. Cheshire, G G Chabot, Miranda Buitenhuis, P Siegenthaler and Jaap Verweij. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Anti-Cancer Drugs and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.